Pictet Asset Management (Switzerland)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $121M | Buy |
1,694,336
+197,720
| +13% | +$14.2M | 0.14% | 177 |
|
|
2023
Q1 | $104M | Buy |
1,496,616
+984,309
| +192% | +$68.3M | 0.13% | 193 |
|
|
2022
Q4 | $34.7M | Buy |
512,307
+129,694
| +34% | +$8.79M | 0.05% | 331 |
|
|
2022
Q3 | $21M | Sell |
382,613
-51,039
| -12% | -$2.8M | 0.03% | 417 |
|
|
2022
Q2 | $28.7M | Buy |
433,652
+13,352
| +3% | +$882K | 0.04% | 385 |
|
|
2022
Q1 | $27.9M | Buy |
420,300
+9,055
| +2% | +$601K | 0.03% | 426 |
|
|
2021
Q4 | $24M | Sell |
411,245
-195,237
| -32% | -$11.4M | 0.02% | 479 |
|
|
2021
Q3 | $73.3M | Buy |
+606,482
| New | +$73.3M | 0.08% | 272 |
|